help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2176
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albers, J. J.
Right arrow Articles by Dabelea, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albers, J. J.
Right arrow Articles by Dabelea, D. M.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Lipid
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 3 735-742
Copyright © 2008 by The Endocrine Society

Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes

John J. Albers, Santica M. Marcovina, Giuseppina Imperatore, Beverly M. Snively, Jeanette Stafford, Wilfred Y. Fujimoto, Elizabeth J. Mayer-Davis, Diana B. Petitti, Catherine Pihoker, Larry Dolan and Dana M. Dabelea

Department of Medicine (J.J.A.), S.M.M.), Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington School of Medicine, Seattle, Washington 98109; Division of Diabetes Translation (G.I.), Centers for Disease Control and Prevention, Atlanta, Georgia 30333; Department of Biostatistical Sciences (B.M.S., J.S.), Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157; Pacific Health Research Institute (W.Y.F.), Honolulu, Hawaii 96813; Department of Epidemiology and Business (E.J.M.-D.), University of South Carolina, Columbia, South Carolina 29208; Department of Preventative Medicine (D.B.P.), University of Southern California, Los Angeles, California 90089; Department of Pediatric Endocrinology (C.P.), Children’s Hospital and Regional Medical Center, Seattle, Washington 98105; Department of Endocrinology (L.D.), Children’s Hospital Medical Center, Cincinnati, Ohio 45229; and Department of Preventative Medicine and Biometrics (D.M.D.), University of Colorado Health Sciences Center, Denver, Colorado 80262

Address all correspondence and requests for reprints to: Santica M. Marcovina, Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington, 401 Queen Anne Avenue North, Seattle, Washington 98109. E-mail: smm{at}u.washington.edu.

Objective: The objective of the study was to assess the prevalence and determinants of elevated apolipoprotein B (apoB) and dense low-density lipoprotein (LDL) in United States youth with type 1 or type 2 diabetes.

Methods: We conducted cross-sectional analyses of apoB concentrations, LDL density, and prevalence of elevated apoB levels and dense LDL from the SEARCH for Diabetes in Youth study, a six-center U.S.-based study of youth with diabetes onset younger than 20 years of age (2657 with type 1 and 345 with type 2).

Results: Among youth with type 1 diabetes, 11% had elevated apoB (≥100 mg/dl, 1.95 mM/liter), 8% had dense LDL (relative flotation rate ≤ 0.237), and 12% had elevated LDL-cholesterol (≥130 mg/dl, 3.36 mM/liter). In contrast, among youth with type 2 diabetes, 36% had elevated apoB, 36% had dense LDL, but only 23% had elevated LDL-cholesterol. Dense LDL and apoB each increased with hemoglobin A1c in both types. Among type 1 diabetics in poor glycemic control (hemoglobin A1c ≥ 9.5%), 28% had elevated apoB, and 18% had dense LDL, whereas 72% of poorly controlled type 2 diabetics had elevated apoB and 62% had dense LDL.

Conclusions: In youth with type 1 diabetes, elevated apoB and dense LDL were not highly prevalent, whereas elevated apoB and dense LDL were common lipoprotein abnormalities in youth with type 2 diabetes. The prevalence of these risk factors substantially increased with poor glycemic control in both groups, stressing the importance of achieving and maintaining an optimal glucose control.




This article has been cited by other articles:


Home page
Diabetes CareHome page
N. A. West, R. F. Hamman, E. J. Mayer-Davis, R. B. D'Agostino Jr., S. M. Marcovina, A. D. Liese, P. S. Zeitler, S. R. Daniels, and D. Dabelea
Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
Diabetes Care, January 1, 2009; 32(1): 175 - 180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society